THE PEPTIDE INTERNET · WITH RECEIPTS PRIMARY RECORDS OVER PRESS RELEASES UNKNOWN IS A REAL ANSWER NO PRODUCTS · NO PROTOCOLS · NO VENDORS EDUCATIONAL JOURNALISM · NOT MEDICAL ADVICE THE PEPTIDE INTERNET · WITH RECEIPTS
The Peptide Current Vol. 1, No. 01 A PepCurrent Publication
We sell nothing. Every claim cited.
About PepCurrent

The sourced version of the peptide internet.

PepCurrent is an independent, evidence-first publication covering peptides and the science behind the claims. It is made for people who heard something online and want a useful answer before the internet turns “interesting” into “proven.”

What makes this different

Most peptide sites answer “What does it do?” PepCurrent asks three earlier questions: what exactly was studied, in whom, and does that evidence belong to the product or claim being discussed?

01 · Exact claim

We check the sentence you actually heard.

Not a vague score for an entire molecule. The claim, outcome, population, route, product, and date stay attached.

02 · Visible receipts

You can inspect the reasoning.

Primary and official sources, evidence limits, cut claims, corrections, and version history remain visible.

03 · Living answer

The page changes when the record changes.

Every priority answer says what changed, which source caused it, and what would change the conclusion again.

What you can do here

How the work is checked

AI systems may help monitor sources, organize evidence, prepare drafts, and perform a separate verification pass. They do not silently publish medical or regulatory conclusions. One system drafts from the source record; a second system rechecks factual claims against primary sources before a separate manual release action. Material medical, safety, and regulatory pages require that second-system review before indexing.

PepCurrent does not accept peptide-vendor advertising, affiliate commissions, sponsored coverage, clinic referrals, or paid product placement. It does not publish dosing, sourcing, reconstitution, stacks, or personalized recommendations. Read the complete methodology, editorial standards, and disclosures.

The publication is the author. PepCurrent uses a publication byline instead of putting an individual’s personal identity on health-adjacent pages. Accountability lives in dated primary sources, public corrections, version history, a separate source-verification pass, and manual publication gates.

Who publishes it—and who pays

The Peptide Current is published by PepCurrent, an independent publication unaffiliated with pharmaceutical companies, peptide manufacturers, clinics, compounding pharmacies, or sellers. It is currently a free, noncommercial public beta. Advertising, sponsorships, affiliates, paid subscriptions, product rankings, and referral programs are paused.

How to reach the publication

The public-beta contact surface stays deliberately small. These are the two operational inboxes PepCurrent will maintain:

Want the changes, not the churn?

The newsletter is designed for material evidence and FDA-status changes—not a daily content treadmill.

Join the early list →